Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000357804

Medchemexpress LLC Elacridar | 143664-11-3 | 99.7% | C34H33N3O5 | 200 MG
SDP

Supplier:  Medchemexpress LLC HY50879200MG

Encompass_Preferred

Elacridar is an orally active inhibitor of P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP). It is utilized to study the impact of efflux transporters on agent distribution to the brain and in cancer research.

  • Examines the influence of efflux transporters on agent distribution to the brain.
  • Used in cancer research.
  • Inhibits cell viability in 786-O cells.
  • Affects P-glycoprotein and ABCG2 protein expression levels in MCF-7 and 786-O cell lines.
  • Increases intracellular accumulation in MCF-7 and 786-O cells.

Catalog No. 50-003-57804


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.